India Share Brokers | Equity Trading India | Derivative Trading in India | Share Brokers in India

Markets Navigation

Company Info.

Astec Lifesciences Ltd.

Income Statement - Consolidated

Market Cap.(`)	2416.05 Cr.	P/BV	5.76	Book Value (`)	213.86
52 Week High/Low ( ` )	1542/825	FV/ML	10/1	P/E(X)	0.00
Book Closure	26/07/2023	EPS (`)	0.00	Div Yield (%)	0.00

(` in Crs.)

You can view the Consolidated Income Statement for the last 5 years.

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	458.18	628.17	676.57	554.87	522.61
Total Operating Revenues	458.18	628.17	676.57	554.87	522.61

Other Income	5.64	13.06	10.47	7.92	11.93
Total Revenue	463.82	641.23	687.03	562.79	534.54

EXPENSES
Cost Of Materials Consumed	318.82	460.83	444.82	344.60	333.44
Purchase Of Stock-In Trade	0.00	0.00	0.00	0.00	0.37
Changes In Inventories Of FG,WIP And Stock-In Trade	0.46	-59.59	-58.00	-2.55	4.73
Employee Benefit Expenses	61.74	52.26	50.31	38.35	29.92
Finance Costs	25.23	20.71	9.06	4.75	12.59
Depreciation And Amortisation Expenses	36.25	33.65	34.36	25.66	23.16
Other Expenses	83.07	98.41	85.37	62.92	68.97
Total Expenses	525.57	606.28	565.91	473.72	473.19

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	-61.75	34.95	121.13	89.07	61.35

Profit/Loss Before Tax	-61.75	34.95	121.13	89.07	61.35

Tax Expenses-Continued Operations
Current Tax	-14.86	0.03	28.63	23.26	16.07
Deferred Tax	0.00	9.33	2.61	-0.61	-3.05
Tax For Earlier Years	0.00	0.00	0.00	1.35	0.80
Total Tax Expenses	-14.86	9.35	31.24	24.00	13.83
Profit/Loss After Tax And Before ExtraOrdinary Items	-46.89	25.59	89.88	65.07	47.53

Profit/Loss From Continuing Operations	-46.89	25.59	89.88	65.07	47.53

Profit/Loss For The Period	-46.89	25.59	89.88	65.07	47.53

Minority Interest	-0.04	-0.03	-0.02	-0.02	-0.02
Consolidated Profit/Loss After MI And Associates	-46.93	25.56	89.86	65.05	47.51

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	-23.93	13.04	45.87	33.23	24.29
Diluted EPS (Rs.)	-23.93	13.04	45.85	33.21	24.27

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	2.94	2.94	2.94	2.93
Tax On Dividend	0.00	0.00	0.00	0.00	0.60

Astec Lifesciences Ltd.

Balance Sheet - Consolidated

Market Cap.(`)	2416.05 Cr.	P/BV	5.76	Book Value (`)	213.86
52 Week High/Low ( ` )	1542/825	FV/ML	10/1	P/E(X)	0.00
Book Closure	26/07/2023	EPS (`)	0.00	Div Yield (%)	0.00

(` in Crs.)

You can view the Consolidated Balance Sheet for the last 5 years.

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	196.09	196.06	195.88	195.88	195.68

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	19.61	19.61	19.60	19.59	19.57
Total Share Capital	19.61	19.61	19.60	19.59	19.57

Reserves and Surplus	349.68	399.40	376.61	289.18	226.33
Total Reserves and Surplus	349.68	399.40	376.61	289.18	226.33
Employees Stock Options	0.00	0.36	0.29	0.42	0.67
Total Shareholders Funds	369.29	419.36	396.50	309.18	246.57
Minority Interest	0.23	0.19	0.16	0.14	0.33

NON-CURRENT LIABILITIES
Long Term Borrowings	199.00	10.86	0.00	40.00	0.00
Deferred Tax Liabilities [Net]	6.76	20.97	8.08	5.47	6.14
Other Long Term Liabilities	2.05	1.35	1.00	0.00	0.00
Long Term Provisions	0.44	0.48	0.43	0.52	0.32
Total Non-Current Liabilities	208.25	33.66	9.51	45.99	6.46

CURRENT LIABILITIES
Short Term Borrowings	294.89	330.32	279.37	147.03	98.71
Trade Payables	89.28	177.18	189.83	124.81	202.39
Other Current Liabilities	11.63	17.95	20.96	49.80	16.72
Short Term Provisions	1.36	0.75	0.43	0.63	0.54
Total Current Liabilities	397.16	526.20	490.59	322.28	318.36

Total Capital And Liabilities	974.93	979.41	896.76	677.59	571.72

ASSETS
NON-CURRENT ASSETS
Tangible Assets	551.00	316.79	337.65	211.55	192.06
Intangible Assets	0.00	1.69	2.30	1.13	1.57
Capital Work-In-Progress	0.00	112.38	13.73	111.68	22.11
Intangible Assets Under Development	0.00	14.22	9.09	4.04	2.00
Fixed Assets	551.00	445.08	362.77	328.39	217.73
Non-Current Investments	0.01	0.01	0.01	0.01	0.01
Deferred Tax Assets [Net]	13.74	0.00	0.00	0.00	0.00
Long Term Loans And Advances	0.00	0.00	0.00	3.34	2.54
Other Non-Current Assets	11.70	35.48	18.30	15.42	19.69
Total Non-Current Assets	576.44	480.56	381.08	347.16	239.97


CURRENT ASSETS
Inventories	195.85	294.85	186.95	106.09	121.17
Trade Receivables	169.00	154.90	273.63	187.15	160.84
Cash And Cash Equivalents	2.43	2.16	2.13	1.57	1.49
Short Term Loans And Advances	0.04	0.02	0.15	0.08	28.91
OtherCurrentAssets	31.17	46.93	52.83	35.54	19.34
Total Current Assets	398.49	498.85	515.68	330.43	331.75

Total Assets	974.93	979.41	896.76	677.59	571.72

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00	256.17	239.82	233.75	274.87

BONUS DETAILS
Bonus Equity Share Capital	0.00	8.57	8.57	8.57	8.57

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	0.00	0.01	0.01	0.01	0.01

Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. | | ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. | "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors" | ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600 | For any Grievance mail to : grievance@sharewealthindia.com | For any DP Grievance mail to : dpgrievance@sharewealthindia.com. | Grievance with SEBI : https://scores.gov.in/scores/Welcome.html

Share Wealth

Astec Lifesciences Ltd.

Income Statement - Consolidated

Astec Lifesciences Ltd.

Balance Sheet - Consolidated